image
Seres Therapeutics, Inc. MCRB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.5497
-7.16 %
$ 93.6 M
Market Cap
-0.46
P/E
INCOME STATEMENT
126 M REVENUE
1672.24%
Growth Rates
1Year 1672.24%
3Years 56.09%
5Years 34.91%
7Years 28.56%
10Years 0.00%
-108 M OPERATING INCOME
56.19%
Growth Rates
1Year 56.19%
3Years -7.01%
5Years -1.49%
7Years -2.18%
10Years -33.40%
-114 M NET INCOME
54.54%
Growth Rates
1Year 54.54%
3Years -8.46%
5Years -2.82%
7Years -3.14%
10Years -33.98%
EFFICIENCY
Earnings Waterfall Seres Therapeutics, Inc.
image
Revenue 126 M
Cost Of Revenue 704 K
Gross Profit 126 M
Operating Expenses 234 M
Operating Income -108 M
Other Expenses 5.74 M
Net Income -114 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 126.3 7.1 144.9 33.2 34.5 28.3 32.1 21.8 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.7 1.0 1.7 90.6 80.1 96.0 89.5 82.0 0.7 10.7 0 0
Gross Profit 125.6 6.1 143.2 (57.4) (45.6) (67.7) (57.4) (60.2) (0.7) (10.7) 0 0
OPERATING INCOME
Operating Expenses 233.6 253.6 209.4 121.3 104.9 128.6 123.5 114.6 54.9 15.1 6.1 3.0
Selling, General and Administrative Expenses 87.7 79.7 69.3 30.8 24.7 32.6 34.0 32.6 16.8 4.4 1.2 1.0
Research and Development Expenses 145.9 172.9 141.9 90.6 80.1 96.0 89.5 82.0 38.1 10.7 4.8 2.1
Operating Income (108.0) (246.5) (64.5) (88.1) (71.9) (100.3) (91.4) (92.8) (54.9) (15.1) (6.1) (3.0)
PRE-TAX INCOME
Interest Income Expense 13.2 6.0 2.9 2.9 0.5 1.2 1.6 1.0 0.6 0 42 K 0
Total Other Income (5.7) (3.7) (1.1) (1.0) 1.6 1.3 2.0 1.3 76 K (1.6) 50 K 93 K
Pre-Tax Income (113.7) (250.2) (65.6) (89.1) (70.3) (98.9) (89.4) (91.6) (54.8) (16.7) (6.1) (3.1)
NET INCOME
Tax Provision 0 3.7 (4.1) (2.7) (6.0) 1.3 (1.6) 2.2 (0.8) 1.6 42 K 0
Net Income (113.7) (253.8) (61.5) (86.5) (64.2) (98.9) (89.4) (91.6) (54.8) (16.7) (6.1) (3.1)
EPS 0.89 2.35 0.67 1.08 1.13 2.43 2.21 2.3 2.33 0.56 0.2 0.15